Bao, Yining
Sun, Yang
Wang, Mengjie
K·Fairley, Christopher
Lu, Pengyi
O’Brien, Terence J.
Su, Shu
Liu, Xin
Wang, Lin
Liu, Hanting
Zhang, Xueli
Shang, Xianwen
Zhu, Zhuoting
Lu, Qianhui
Li, Zengbin
Lai, Hao
Wang, Jing
Ma, Ting
Wang, Liqin
Xie, Xinxin
Wang, Wenhua
Wu, Wenjie
Yang, Jiangcun
Zhang, Lei
Funding for this research was provided by:
Ministry of Science and Technology of the People's Republic of China (2022YFC2304900)
National Key Research and Development Program of China (2022YFC2505100)
Article History
Received: 28 August 2024
Accepted: 28 July 2025
First Online: 24 September 2025
Declarations
:
: Ethical approval for our study was obtained from the institutional review board of the People’s Hospital of Shaanxi Province (No: 2020-R002). All research procedures adhere to the committee’s ethical standards and regulations. All participants provided informed consent.This study was pre-registered at China National Medical Research Register and Chinese Clinical Trial Registry, the Clinical Trial Number is MR-61–21-011750 and ChiCTR2200055983, respectively. The Registration Date of this clinical trial is 30/01/2022.
: Not applicable.
: The authors declare no competing interests.